Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Paclitaxel and Carboplatin in Stage II/III NSCLC
NCT00077220Phase 3Unknown
- Sponsor
- GERCOR
- Start
- Jun 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, carboplatin in non-small cell lung cancer (NSCLC), sponsored by GERCOR. Status: unknown.
02
Drugs
paclitaxelcarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00077220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077220.